In addition, the pharmacological inhibition or RNA interference-mediated inactivation of PAFAH1B3 could impair cancer cell survival, migration and invasiveness in vitro and slow tumor growth in vivo (10, 11, 21). The gene discussed is PAFAH1B3; the disease is neoplasm.